South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, ...

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid by other developed ...

For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

Trump’s move “actually is a step backward because he is rolling back the steps taken to promote negotiation under Medicare of ...